Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

RVC discovers high antibiotic use in Indian chicken farming
Antibiotics were used as a risk mitigation strategy in the early stages of production.
Critically important human antibiotics were used routinely in early production.

New research from the Royal Veterinary College (RVC) has revealed the extent that critically important human antibiotics are used in Indian chicken farming.

In collaboration with the West Bengal University of Animal & Fishery Sciences, the RVC found that poultry companies were having a more significant role in antibiotic use than chicken farmers.

The project saw a team of researchers interview 43 poultry stakeholders in Kolkata and the surrounding area of West Bengal in India between March 2021 and March 2022. This included farmers, poultry veterinary professionals, government veterinary teams, poultry company employees and poultry dealers.

The data was then examined using an economic framework called ‘agency theory’ to help examine the antibiotic use decisions.

The researchers found that most poultry farming occurred through contract farming arrangements. This was consistent with the wider image of India, where 80 per cent of poultry farming is performed under these conditions.

These chickens are frequently kept in housing which is open to the environment, meaning they are exposed to high temperatures, humidity and exposure to infectious diseases. This leads to antibiotics being used as a risk mitigation strategy to protect the birds during production.

The data also revealed that many stakeholders were concerned about the risk that the bacteria Mycoplasma poses to chicks. These concerns prompted stakeholders to use antibiotics routinely at the start of production.

The antibiotics used often belong to the classes which are considered critically important to human health – fluoroquinolone and macrolide antibiotics. RVC says that these antibiotics should never be routinely used for livestock production.

Many poultry companies have said that, though they do use antibiotic alternatives, they are expensive and not sufficient for protecting birds.

Mat Hennessy, the post-doctoral researcher from RVC who led the team, said: “Given the dominance of contract farming in chicken production in India, corporations are well positioned to coordinate a strategy towards lowering antibiotic use.

“However, these strategies should consider the wider infrastructural, institutional, and political environment within which chicken production occurs to promote antibiotic use in socially responsible ways.”

The full study can be found in the journal Plos One.

Image © RVC

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.